These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 343972)

  • 1. [Treatment of degenerative and inflammatory joint diseases with or without a new synthetic substance (parsalmide). Controlled clinical trial].
    Napoli A; Alderuccio B; Nannetti A
    Clin Ter; 1977 Dec; 83(5):541-7. PubMed ID: 343972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Report of a controlled clinical trial of a new synthetic drug, parsalmide, in rheumatic arthropathies (inflammatory and degenerative)].
    Sanguinetti CM; Bonifazi F
    Minerva Med; 1976 Oct; 67(52):3391-5. PubMed ID: 792738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled clinical trial of a new synthetic preparation (parsalmide) in the treatment of inflammatory and degenerative arthro-myopathies].
    Franchi R
    Minerva Med; 1976 Oct; 67(52):3397-402. PubMed ID: 792739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled clinical trial of parsalmide, a drug with analgesic and anti-inflammatory activity].
    Tafner G; Pedrazzoli M; Bajocchi E
    Minerva Med; 1976 Oct; 67(52):3383-90. PubMed ID: 792737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parsalmide, a new synthetic substance, in inflammatory and arthrosic arthropathies. Double-blind controlled clinical trial].
    Menci S; Rossi M; Del Curatolo G; Orsucci PL
    Minerva Med; 1976 Oct; 67(52):3403-8. PubMed ID: 792740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled clinical trial of parsalmide in patients with subacute and chronic arthro-neuro-mypathies].
    Farneti P; Colombo I
    Minerva Med; 1976 Oct; 67(52):3377-82. PubMed ID: 792736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Controlled clinical trial of parsalmide].
    Bajardi A; Fantato S
    Minerva Med; 1976 Oct; 67(52):3371-5. PubMed ID: 792735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Controlled clinical experimentation of a new synthetic preparation (MY 41-6) with anti-inflammatory, antalgic and myorelaxant effect].
    Capretti G; Marinoni C
    Clin Ter; 1974 Feb; 68(3):233-45. PubMed ID: 4596251
    [No Abstract]   [Full Text] [Related]  

  • 9. ["Double-blind" clinical study of a non-steroid anti-inflammatory drug: glucametacine].
    Pipino F; Franchin F
    Minerva Med; 1980 Oct; 71(39):2845-50. PubMed ID: 7001282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Double-blind comparative study of difenpyrammide and indomethacin in clinical research with patients].
    Diamantopulos P; Miccoli G
    Clin Ter; 1979 Jan; 88(1):33-44. PubMed ID: 373973
    [No Abstract]   [Full Text] [Related]  

  • 11. Fenbufen and indomethacin in the treatment of rheumatoid arthritis. A comparative double-blind, crossover study.
    Ammitzbøll F
    Scand J Rheumatol Suppl; 1979; (23):5-10. PubMed ID: 373083
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment in rheumatology with a new injectable salt of indomethacin].
    Coari G; Taccari E
    Minerva Med; 1974 Mar; 65(17):917-22. PubMed ID: 4545238
    [No Abstract]   [Full Text] [Related]  

  • 13. [Preliminary observations on the clinical use of the glucosamide of N-p-chlorobenzoyl-2-methyl-5-methoxy-indol-3-acetic acid monohydrate].
    Montini M; Ongaro A; Pagani G
    Reumatismo; 1972; 24(1):57-68. PubMed ID: 4546498
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the use of a new injectable antirheumatic-antiarthritic drug in some diseases of orthopedic importance].
    Salvagni A
    Minerva Med; 1967 Mar; 58(18 Suppl):753-6. PubMed ID: 5297787
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study with isonixine].
    Asensi E; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1977; 20(2):159-67. PubMed ID: 327518
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of Prolixan 300 (Azapropazone) on the course of rheumatoid disease and degenerative joint disease. Comparison with indomethacin by means of a double blind test].
    Kawenoki-Minc E; Gburek Z; Sadkiewicz S; Keller B; Piotrowska E; Rajpert D; Reszkowska H
    Reumatologia; 1979; 17(3):365-74. PubMed ID: 390661
    [No Abstract]   [Full Text] [Related]  

  • 18. Double blind trial involving: Teorema, a new antirheumatic, vs. indometacin in rheumatoid diseases.
    Petera P; Tausch G; Bröll H; Eberl R
    Int J Clin Pharmacol Biopharm; 1977 Dec; 15(12):581-4. PubMed ID: 340390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [2-(4-Isobutylphenyl)-propionic acid in the treatment of rheumatic diseases: clinical effects and tolerance].
    Viara M
    Minerva Med; 1973 Jun; 64(47):2513-4. PubMed ID: 4579843
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of chronic polyarthritis with pirprofen or indomethacin. Interindividual double-blind trial].
    Grasedyck K; Filchner R; Gross W
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):170-2. PubMed ID: 3872825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.